Tag: Depot injection

Did you know that poor adherence to daily oral antipsychotic medication is a major factor in relapses and hospitalizations for people with schizophrenia? To address this, healthcare providers often recommend what is colloquially known as a schizophrenic shot, which are long-acting injectable (LAI) medications designed to provide a steady supply of medication over an extended period.

For some chronic conditions, maintaining consistent medication levels can be a significant challenge, with non-adherence being a major concern. A specialized treatment, known as a **depot injection**, offers a solution by providing a steady, slow-releasing supply of medication over an extended period.

According to research, medication-assisted treatment for opioid use disorder (OUD) using long-acting buprenorphine significantly improves treatment adherence and patient outcomes compared to daily medication. A Buvidal injection is a key example, containing the active ingredient buprenorphine and used to manage opioid dependence in adults and adolescents over 16.